Scholar Rock

Scholar Rock - Overview

Scholar Rock Holding Corp. is a leading biotechnology company focused on developing innovative therapies for serious diseases. The company leverages its proprietary platform to discover and develop transformative drug candidates that target unmet medical needs. Scholar Rock’s commitment to precision medicine and novel therapeutic approaches aims to improve patient outcomes and advance the field of biotechnology.

Products and Pipeline:

• Drug Candidates: Scholar Rock is advancing a portfolio of drug candidates in various stages of development, targeting diseases with high unmet needs. Key areas of focus include oncology, neuromuscular diseases, and fibrosis.
  • SRK-015: A clinical-stage therapeutic designed to treat neuromuscular diseases by targeting muscle growth and function.
  • SRK-181: A program aimed at overcoming resistance in cancer treatment by targeting the tumor microenvironment.
  • Other Pipeline Programs: Includes research into additional novel therapies for serious and rare diseases.

Technology Platform:

• Proprietary Platform: Scholar Rock’s technology platform is based on the discovery and development of novel protein-targeted therapies. The platform focuses on controlling the activation of latent proteins to unlock new treatment opportunities for a range of diseases.

Market Presence:

• Regional Focus: Scholar Rock operates primarily in North America, with expanding collaborations and partnerships in Europe and other international markets.
• Global Reach: The company’s research and development efforts are supported by a network of global partnerships, collaborations, and clinical trials.

Scholar Rock Market Portfolio | Comprehensive Overview

Browse Our Research Portfolio In Scholar Rock Markets

Scholar Rock features in

Industries

Health Care

Segments

Pharmaceuticals

Markets

Pharmaceuticals